![Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative. - ppt download Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative. - ppt download](https://slideplayer.com/13201904/79/images/slide_1.jpg)
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative. - ppt download
![Aggressive treatment for some stage IV lung cancer patients can dramatically improve overall survival - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO) Aggressive treatment for some stage IV lung cancer patients can dramatically improve overall survival - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO)](https://www.astro.org/ASTRO/media/ASTRO/News%20and%20Publications/News%20Releases/LongTermSurvival.jpg?ext=.jpg)
Aggressive treatment for some stage IV lung cancer patients can dramatically improve overall survival - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO)
![Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis | European Respiratory Society Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis | European Respiratory Society](https://erj.ersjournals.com/content/erj/53/6/1801568/F3.large.jpg)
Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis | European Respiratory Society
![Surgery versus stereotactic body radiotherapy in medically operable non-small cell lung cancer - Ong - Journal of Xiangya Medicine Surgery versus stereotactic body radiotherapy in medically operable non-small cell lung cancer - Ong - Journal of Xiangya Medicine](https://cdn.amegroups.cn/journals/ales/files/journals/28/articles/4571/public/4571-PB3-7642-R1.png)
Surgery versus stereotactic body radiotherapy in medically operable non-small cell lung cancer - Ong - Journal of Xiangya Medicine
![Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? | British Journal of Cancer Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-018-0201-z/MediaObjects/41416_2018_201_Fig1_HTML.png)
Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? | British Journal of Cancer
![Stereotactic Body Radiation Therapy an Effective Option for Early-Stage Lung Cancer Patients - The ASCO Post Stereotactic Body Radiation Therapy an Effective Option for Early-Stage Lung Cancer Patients - The ASCO Post](https://ascopost.com/media/3765/51409_chart.jpg)
Stereotactic Body Radiation Therapy an Effective Option for Early-Stage Lung Cancer Patients - The ASCO Post
![Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival - ScienceDirect Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500217303082-gr1a.jpg)
Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival - ScienceDirect
![Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients](https://www.jcancer.org/v10/p0168/jcav10p0168g001.jpg)
Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients
![Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection - The Journal of Thoracic and Cardiovascular Surgery Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection - The Journal of Thoracic and Cardiovascular Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/41de99d9-636a-4638-a3b6-8c8b820ceebd/gr1.jpg)
Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection - The Journal of Thoracic and Cardiovascular Surgery
![Palliative care for patients with locally advanced and metastatic non-small cell lung cancer - Simone II - Annals of Palliative Medicine Palliative care for patients with locally advanced and metastatic non-small cell lung cancer - Simone II - Annals of Palliative Medicine](https://cdn.amegroups.cn/journals/amepc/files/journals/8/articles/2650/public/2650-PB4-R1.png)
Palliative care for patients with locally advanced and metastatic non-small cell lung cancer - Simone II - Annals of Palliative Medicine
![Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature | Future Science OA Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature | Future Science OA](https://www.future-science.com/cms/10.2144/fsoa-2019-0120/asset/images/medium/figure1.gif)
Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature | Future Science OA
![Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/6f0f6a26-4650-4185-9b00-fee9630157e6/gr1.jpg)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study - The Lancet ... Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study - The Lancet ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2117427411/2085530473/gr1.gif)
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study - The Lancet ...
![Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non–Small Cell Lung Cancer: A National Cancer Database Study | Radiology Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non–Small Cell Lung Cancer: A National Cancer Database Study | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2018180979/asset/images/medium/radiol.2018180979.fig1.gif)
Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non–Small Cell Lung Cancer: A National Cancer Database Study | Radiology
![Risk of second primary lung cancer in women after radiotherapy for breast cancer - Radiotherapy and Oncology Risk of second primary lung cancer in women after radiotherapy for breast cancer - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2023179681/2043609460/gr1.jpg)
Risk of second primary lung cancer in women after radiotherapy for breast cancer - Radiotherapy and Oncology
![Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab - Clinical Lung Cancer Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e337cfbd-aa4c-4910-a943-68a04a9c8052/gr1_lrg.jpg)
Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab - Clinical Lung Cancer
![Recurrence After Stereotactic Body Radiation Therapy Versus Lobectomy for Non-Small Cell Lung Cancer - The Annals of Thoracic Surgery Recurrence After Stereotactic Body Radiation Therapy Versus Lobectomy for Non-Small Cell Lung Cancer - The Annals of Thoracic Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0aad09a7-c906-4861-9bfe-3e0c2057d354/gr1.jpg)